Table 2 Prevalence of rifampicin resistance among TB patients in the survey, overall and by previous anti-TB treatment history
From: Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste
Total TB cases | RR-TB | % (95% CI) | |
|---|---|---|---|
New patients | 844 | 5 | 0.6 (0.2–1.3) |
Previously treated patients | 73 | 2 | 2.7 (0.5–8.2) |
All patients | 917 | 7 | 0.8 (0.3–1.5) |